Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-13.7%
5Y CAGR-5.1%
Year-over-Year Change
Research and development spending
3Y CAGR
-13.7%/yr
vs -0.2%/yr prior
5Y CAGR
-5.1%/yr
Recent deceleration
Acceleration
-13.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.71M | +0.5% |
| 2024 | $12.65M | -86.4% |
| 2023 | $93.15M | +370.7% |
| 2022 | $19.79M | +16.8% |
| 2021 | $16.94M | +2.7% |
| 2020 | $16.50M | -12.5% |
| 2019 | $18.84M | -5.4% |
| 2018 | $19.92M | +75.1% |
| 2017 | $11.38M | +0.0% |
| 2016 | $11.37M | - |